-i(BORRELIA BURGDORFERI) BACTERIN
Abstract
A BACTERINA IS PROVIDED immunizing AMOUNTS INCLUDING TWO EFFECTIVE PROTECTION ISOLATED NOT CROSSED ISOLATED Borrelia burgdorferi an adjuvant IN SUFFICIENT TO IMPROVE immunogenicity of Borrelia burgdorferi isolates deactivated and a suitable carrier. The bacterin may also contain THIRD CRUSADE NO PROTECTION ISOLATED. SE also facilitates BACTERINA INCLUDING AMOUNTS immunizing EFFECTIVE subunit ANTIGENIC ARISING FROM A FIRST ISOLATED Borrelia burgdorferi AND A SECOND ISOLATED Borrelia burgdorferi PROTECTION uncrossed, an adjuvant sufficient to enhance immunogenicity of the subunits ANTIGENIC QUANTITY AND PROPER VEHICLE. The bacterin may also contain a immunizing amount EFFECTIVE antigenic subunit A THIRD Borrelia burgdorferi. ALSO it IS PROVIDED A BACTERINA INCLUDING AMOUNTS immunizing EFFECTIVE ISOLATED PROTECTION NOT CROSS inactivated Borrelia burgdorferi TWO AND ONE OR MORE subassemblies ISOLATED PROTECTION uncrossed, an adjuvant IN SUFFICIENT TO IMPROVE QUANTITY INMUGENICIDAD OF inactivated Borrelia burgdorferi and sub-units ANTIGENIC well as an appropriate vehicle. Methods are also provided to immunize an animal against infection by Borrelia burgdorferi which involve administering to the animal a dose of BACTERINA DESCRIBED.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
18 members in 9 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 22629794 | United States of America | A | |
| 22629794 | United States of America | A | |
| 226297 | – | – | – |
| US19940226297 | – | – | – |
Members18
| Document | Office | Kind | |
|---|---|---|---|
| CA2187535A1 | Canada | A1 | |
| WO9527504A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0757556A1 | European Patent Office (EPO) | A1 | |
| EP0757556A4 | European Patent Office (EPO) | A4 | |
| US6316005B1 | United States of America | B1 | |
| US2002071851A1 | United States of America | A1 | |
| US2005042235A1 | United States of America | A1 | |
| EP0757556B1 | European Patent Office (EPO) | B1 | |
| AT329615TThis record | Austria | T | |
| ATE329615T1 | Austria | T1 | |
| DE69535059D1 | Germany | D1 | |
| DK0757556T3 | Denmark | T3 | |
| PT757556E | Portugal | E | |
| DE69535059T2 | Germany | T2 | |
| ES2265643T3 | Spain | T3 | |
| US2008026009A1 | United States of America | A1 | |
| CA2187535C | Canada | C | |
| US2011256178A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 329615
- Publication, EPODOC
- AT329615T
- Application
- 95916950
- Application, DOCDB
- 95916950
- Application, EPODOC
- AT19950916950T
Titles2
- German
- BORRELIA BURGDORFERI BACTERIN
- English
- BORRELIA BURGDORFERI BACTERIN
Classification
- CPC, 10
- A61K39/0225
- A61K39/00
- A61K2039/521
- A61K2039/55505
- A61P31/04
- C07K14/20
- A61P37/04
- Y10S424/828
- Y02A50/30
- Y10S514/825
- IPC, 4
- A61K39 00
- A61K39 02
- A61P31 04
- C07K14 20